SPDR® S&P Pharmaceuticals ETF (XPH)
| 46.35 Delayed Data As of Nov 29 |  -0.74 / -1.57%Today’s Change | 46.12 Today|||52-Week Range 56.32 | -10.97% Year-to-Date |
Investment Objective
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Latest XPH News
No recent news for SPDR® S&P Pharmaceuticals ETF.
Performance
| 1 month | -1.63% | 3 years | +4.07% | |
| 3 months | -2.54% | 5 years | +3.66% | |
| 1 year | -0.97% | Since inception | +9.26% |
Data through 11/27/2021
Quote Details
| Previous close | $47.09 |
| Open day’s range | 46.35 – 47.25 |
| Net asset value (NAV) | 47.11 (11/26/2021) |
| Daily volume | 42,255 |
| Average volume (3 months) | 55,222 |
Data as of 4:00pm ET, 11/29/2021
Peer Comparisonvs. Health ETFs
| XPH | Category | |
|---|---|---|
| Performance 5-yr return | +3.66% | +13.75% |
| Expense Gross exp ratio | 0.35% | 1.00% |
| Risk 5 year sharpe ratio | 0.26 | 0.91 |
| Net assets | $232.5M | $2.4B |
| Average market cap | $11.7B | $37.7B |
| Average P/E | 17.3 | 25.0 |
| Dividend / Share | -- | 0.29% |
Competitors
| RYH Invesco S&P 500® Equal Weight Health Ca... |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| MRK Merck | 5.36% |
| OGN Organon & Co | 4.85% |
| LLY Eli Lilly and Co | 4.75% |
| ZTS Zoetis Inc | 4.67% |
| PRGO Perrigo Company PLC | 4.62% |
| RPRX Royalty Pharma PLC | 4.59% |
| CTLT Catalent Inc | 4.47% |
| JAZZ Jazz Pharmaceuticals PLC | 4.42% |
| ELAN Elanco Animal Health Inc | 4.40% |
| JNJ Johnson & Johnson | 4.36% |
